Module 5: Specialty Disease Management II: Neurology, Rare & Infectious
Mastering the Frontiers of High-Acuity Specialty Care.
From Broad Pathways to Precision Targets
Welcome to Module 5. In Module 4, we built a foundational mastery of the “pillars” of specialty pharmacy: oncology and immunology. While clinically distinct, those fields are often linked by their pharmacology, focusing on modulating or suppressing the immune system and cell growth pathways.
In this module, we transition to a new set of disease states that represent the absolute pinnacle of pharmacist specialization. These are conditions that are often more complex, higher-touch, and require a more profound level of logistical and clinical coordination. You will move from managing broad inflammatory pathways to navigating the intricacies of the central nervous system, from managing multi-million dollar “one-time” orphan drugs to co-managing lifelong, curative antiviral regimens.
Your expertise will be tested as you master therapies for multiple sclerosis, where adherence and monitoring are paramount; rare and orphan diseases, where you are the sole logistical link to a life-saving therapy; HIV and HCV, where you are a true partner in a cure; and solid organ transplant, where a single pharmacokinetic error is a life-or-death event. This module is designed to build your expertise in the fastest-growing and most clinically-demanding areas of specialty practice.
Your Guide to High-Acuity Specialty Care
This module will equip you with the advanced clinical and operational skills required to manage some of the most complex patient populations in medicine.
Neurologic Specialty Disorders and Treatment Algorithms
An overview of complex neurologic conditions (e.g., Parkinson’s, Huntington’s, Alzheimer’s) and the pharmacist’s role in managing polypharmacy and complex dosing algorithms.
Multiple Sclerosis, ALS, and Epilepsy Therapies
A deep dive into the diverse pharmacologic arsenal for MS (DMTs), ALS, and refractory epilepsy, focusing on adherence, monitoring, and toxicity management.
Rare Disease and Orphan Drug Programs
Exploring the unique ultra-high-cost landscape of orphan drugs, gene therapies, and the pharmacist’s critical role in navigating limited distribution networks and patient support programs.
HIV, HCV, and Advanced Infectious Disease Models
Mastering the curative and suppressive antiviral regimens for HCV and HIV, focusing on drug-drug interactions, resistance, and the pharmacist’s role as a long-term care provider.
Transplant Medicine and Immunosuppression Management
A high-stakes exploration of solid organ transplant pharmacology, including immunosuppressant protocols, therapeutic drug monitoring (TDM), and managing post-transplant complications.